Delivery Order SPE2DB20D1004-SPE2DB24FG0J9
Award Date 5/15/24
Potential Completion Date 5/16/24
Potential Value $3.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,933.40, is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a prescription medication. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PRADAXA 150 MG CAPSULE in quantities of 60s, with a ceiling value of $1,314.36. The order has a firm fixed price, with a completion date of July 25, 2022. This contract is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,630.94 firm-fixed price delivery order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a cardiovascular medication. The contract has an ultimate completion date of October 13, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,554,756,127 units of the drug PRADAXA 150 MG CAPSULE. The contract has a firm fixed price ceiling value of $1,334.33 and an ultimate completion date of September 14, 2021. The contract is a delivery order without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,115.91, for the provision of Pradaxa 150 mg capsules. The contract is not designated with a set-aside, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,383.95 firm fixed-price delivery order is for the supply of PRADAXA 150 MG CAPSULE, a cardiovascular medication. The award has an ultimate completion date of September 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,033.98 firm fixed-price delivery order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,018.15 firm fixed price delivery order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a prescription medication. The contract has an ultimate completion date of April 1, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both...
- This federal contract award, valued at $1,094.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a period of performance through January 4, 2024, is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a prescription medication. The contract is structured as a Firm Fixed Price Delivery Order, with no specific set-aside designation noted. Amerisourcebergen holds a larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pradaxa 150 mg capsules, with a ceiling value of $9,809.06 and a performance period through December 22, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FG0J9Delivery Order
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,699.03 and a completion date of May 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award does not have a set-aside designation, indicating open competition.
Generated 5/16/25, 12:43 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 5/15/24 |